Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization
- DOI
- 10.1080/07853890.2026.2720965
- Published
- 2026-08-24
- Container
- Annals of Medicine
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/07853890.2026.2720965,
title = {Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization},
author = {Yu Wang and Haihong Qin and Yuwen Gao and Zheng Li and Yuemeng Wu and Huibin Yin and Shangshang Wang and Xu Yao and Hao Wu and Chaoying Gu},
year = {2026},
journal = {Annals of Medicine},
doi = {10.1080/07853890.2026.2720965},
url = {https://doi.org/10.1080/07853890.2026.2720965}
}RIS
TY - JOUR TI - Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization AU - Yu Wang AU - Haihong Qin AU - Yuwen Gao AU - Zheng Li AU - Yuemeng Wu AU - Huibin Yin AU - Shangshang Wang AU - Xu Yao AU - Hao Wu AU - Chaoying Gu PY - 2026 JO - Annals of Medicine DO - 10.1080/07853890.2026.2720965 UR - https://doi.org/10.1080/07853890.2026.2720965 ER -
APA
Wang, Y., Qin, H., Gao, Y., Li, Z., Wu, Y., Yin, H., Wang, S., Yao, X., Wu, H., & Gu, C. (2026). Clinical and inflammatory determinants of successful abrocitinib dose reduction in atopic dermatitis: a real-world cohort study with implications for treatment optimization. Annals of Medicine. https://doi.org/10.1080/07853890.2026.2720965
Source records
- crossref · retrieved 2026-09-26T15:43:19.875Z